目的探讨18 ku转位蛋白TSPO选择性配体YL-IPA08对皮质酮诱导BV-2细胞凋亡的保护作用,并研究其可能的作用机制。方法选择性TSPO配体YL-IPA08 1-100 nmol·L(-1)和(或)TSPO拮抗剂PK11195 100 nmol·L(-1)预处理小胶质细胞系BV-2细胞2 h,加入皮质酮200μmol·L(-1)继续培养24 h,分别用流式细胞术检测细胞凋亡,CCK-8法检测细胞存活,Western蛋白质印迹法检测TSPO蛋白表达水平,ELISA法检测细胞培养上清中四氢孕酮的水平。结果与溶剂对照组相比,YL-IPA08 1-100 nmol·L(-1)与阳性化合物AC-5216一样能降低皮质酮处理的BV-2细胞的凋亡率(P〈0.01),且100 nmol·L(-1)时作用最为显著,该作用能被PK11195 100 nmol·L(-1)所拮抗(P〈0.05)。细胞活性检测显示,YL-IPA08 100 nmol·L(-1)时能显著升高细胞活性(P〈0.01),PK11195 100 nmol·L(-1)处理会拮抗该作用(P〈0.01)。Western蛋白质印迹和ELISA法结果显示,YL-IPA08 100 nmol·L(-1)时能显著增加皮质酮处理的BV-2细胞TSPO蛋白的表达(P〈0.05)并显著升高培养液中四氢孕酮的水平(P〈0.05),PK11195 100 nmol·L(-1)显著逆转该现象,降低四氢孕酮的水平(P〈0.05)。结论 YL-IPA08显著抑制皮质酮诱导BV-2细胞的凋亡,表现出对小胶质细胞的保护作用,该作用与其增加TSPO蛋白的表达、升高四氢孕酮的水平密切相关。
OBJECTIVE To investigate the protective effect of selective 18 ku translocator protein(TSPO) ligand YL-IPA08 on corticosterone(CORT)-induced apoptosis of BV-2 cel s and its potential mechanisms. METHODS BV-2 Cells were pretreated with selective TSPO ligand YL-IPA08 1-100 nmol·L(-1)and(or) TSPO antagonist PK11195 100 nmol·L-1for 2 h,and then co-incubated with CORT for another24 h. The apoptosis rate was measured by flow cytometry. CCK-8 kit was used to test BV-2 cell viability. The protein expression of TSPO was determined by Western blotting. The level of allopregnanolone was detected by ELISA kit. RESULTS In line with positive drug-AC-5216, the cell apoptosis rate decreased in YL-IPA08 1-100 nmol·L(-1)and CORT co-treatment groups(P0.01), which was antagonized by PK11195 100 nmol·L(-1)treatment(P0.05). Cell viability increased in YL-IPA08 100 nmol·L(-1)and CORT co-treatment groups(P0.01), which was blocked by PK11195 100 nmol·L(-1)treatment(P0.01).The expression of TSPO and the level of allopregnanolone(P0.01) were enhanced by YL-IPA08100 nmol·L-1pretreatment followed by CORT treatment. The enhancement of allopregnanolone level was blocked by PK11195 100 nmol·L(-1)treatment(P0.05). CONCLUSION YL-IPA08 can protect BV-2cells from CORT induced apoptosis. The protective effect of YL-IPA08 may be conferred by the increasing level of TSPO expression and allopregnanolone.